Early disease detection: the value of feline health screening

2018 ◽  
pp. 62-63
Author(s):  
Sarah Caney
2019 ◽  
Vol 102 (6) ◽  
pp. 5389-5402 ◽  
Author(s):  
G.L. Lowe ◽  
M.A. Sutherland ◽  
J.R. Waas ◽  
A.L. Schaefer ◽  
N.R. Cox ◽  
...  

2003 ◽  
Vol 84 (2) ◽  
pp. 137-145 ◽  
Author(s):  
Cédric Bravo ◽  
Dimitrios Moshou ◽  
Jonathan West ◽  
Alastair McCartney ◽  
Herman Ramon

2005 ◽  
Vol 25 (1-2) ◽  
pp. 107-125 ◽  
Author(s):  
Katherine R. Calvo ◽  
Lance A. Liotta ◽  
Emanuel F. Petricoin

The discovery of new highly sensitive and specific biomarkers for early disease detection and risk stratification coupled with the development of personalized “designer” therapies holds the key to future treatment of complex diseases such as cancer. Mounting evidence confirms that the low molecular weight (LMW) range of the circulatory proteome contains a rich source of information that may be able to detect early stage disease and stratify risk. Current mass spectrometry (MS) platforms can generate a rapid and high resolution portrait of the LMW proteome. Emerging novel nanotechnology strategies to amplify and harvest these LMW biomarkers in vivo or ex vivo will greatly enhance our ability to discover and characterize molecules for early disease detection, subclassification and prognostic capability of current proteomics modalities. Ultimately genetic mutations giving rise to disease are played out and manifested on a protein level, involving derangements in protein function and information flow within diseased cells and the interconnected tissue microenvironment. Newly developed highly sensitive, specific and linearly dynamic reverse phase protein microarray systems are now able to generate circuit maps of information flow through phosphoprotein networks of pure populations of microdissected tumor cells obtained from patient biopsies. We postulate that this type of enabling technology will provide the foundation for the development of individualized combinatorial therapies of molecular inhibitors to target tumor-specific deranged pathways regulating key biologic processes including proliferation, differentiation, apoptosis, immunity and metastasis. Hence future therapies will be tailored to the specific deranged molecular circuitry of an individual patient's disease. The successful transition of these groundbreaking proteomic technologies from research tools to integrated clinical diagnostic platforms will require ongoing continued development, and optimization with rigorous standardization development and quality control procedures.


Micromachines ◽  
2019 ◽  
Vol 10 (4) ◽  
pp. 251 ◽  
Author(s):  
Nicolaos Christodoulides ◽  
Michael P. McRae ◽  
Glennon W. Simmons ◽  
Sayli S. Modak ◽  
John T. McDevitt

The McDevitt group has sustained efforts to develop a programmable sensing platform that offers advanced, multiplexed/multiclass chem-/bio-detection capabilities. This scalable chip-based platform has been optimized to service real-world biological specimens and validated for analytical performance. Fashioned as a sensor that learns, the platform can host new content for the application at hand. Identification of biomarker-based fingerprints from complex mixtures has a direct linkage to e-nose and e-tongue research. Recently, we have moved to the point of big data acquisition alongside the linkage to machine learning and artificial intelligence. Here, exciting opportunities are afforded by multiparameter sensing that mimics the sense of taste, overcoming the limitations of salty, sweet, sour, bitter, and glutamate sensing and moving into fingerprints of health and wellness. This article summarizes developments related to the electronic taste chip system evolving into a platform that digitizes biology and affords clinical decision support tools. A dynamic body of literature and key review articles that have contributed to the shaping of these activities are also highlighted. This fully integrated sensor promises more rapid transition of biomarker panels into wide-spread clinical practice yielding valuable new insights into health diagnostics, benefiting early disease detection.


Sign in / Sign up

Export Citation Format

Share Document